Teva Pharmaceuticals Director of Business Development Salaries in Dover, DE
The average Teva Pharmaceuticals Director of Business Development in Dover, DE earns an estimated $215,806 annually, which includes an estimated base salary of $166,059 with a $49,747 bonus. Teva Pharmaceuticals' Director of Business Development compensation is $49,540 more than the US average for a Director of Business Development. Director of Business Development salaries at Teva Pharmaceuticals in Dover, DE can range from $73,000 - $390,000.
In Dover, DE, The Business Development Department at Teva Pharmaceuticals earns $7,733 more on average than the Marketing Department.
Last updated 10 months ago.
- $166,059
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at Teva Pharmaceuticals
In Dover, DE, Directors of Business Development earn $2,870 more than Directors of Business Development.
Compensation at Teva Pharmaceuticals by Department
In Dover, DE, The Business Development Department averages $7,733 more than the Marketing Department, and $2,198 less than the Engineering Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Teva Pharmaceuticals reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Teva Pharmaceuticals reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Teva Pharmaceuticals Rate Their Compensation
The majority of Directors of Business Development at Teva Pharmaceuticals believe they're not compensated fairly. 100% of Directors of Business Development at Teva Pharmaceuticals say they receive annual bonuses, and the majority (63%) are satisfied with their benefits. See more compensation ratings at Teva Pharmaceuticals
